Please Contact U.S. Medical Information — Rockland, Massachusetts

Please Contact U.S. Medical Information is a clinical research site located in Rockland, Massachusetts, United States.

Crixeo Clinical Trials Trust Score: 10/100 (FAILING). This profile has not yet been claimed by the site owner.

Please Contact U.S. Medical Information has participated in 4 clinical trials.

Therapeutic areas: Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma, Relapsing-remitting Multiple Sclerosis, Melanoma.

Sponsors: ImmunoGenesis, EMD Serono Research & Development Institute, Inc., EMD Serono.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Rockland

Browse all research sites in Massachusetts · View every site in Rockland

Sponsor Feasibility Report

Trust Score: 10/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Please Contact U.S. Medical Information?

Please Contact U.S. Medical Information has a Crixeo Trust Score of 10/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Please Contact U.S. Medical Information conducted?

Please Contact U.S. Medical Information has 4 clinical trials on record. Their work covers Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma, Relapsing-remitting Multiple Sclerosis, Melanoma.

Is Please Contact U.S. Medical Information accredited by Crixeo Clinical Trials?

Please Contact U.S. Medical Information has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Please Contact U.S. Medical Information?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.